M
Moderna Therapeutics
Biotech & Life Sciences · Cambridge, United States · Founded 2010 · IPO 2018
News
Moderna to raise $2B in convertible notes after cancer vaccine rally
Aug 27, 2026
Analysis
Moderna vs BioNTech Valuation
Aug 22, 2026
News
Moderna and Merck's cancer vaccine intismeran hits both endpoints in Phase 3 melanoma trial
Aug 19, 2026
News
Blackstone invests $250M in Anagram to cut the pill burden for cystic fibrosis patients
May 7, 2026
Talent graph
Moderna Therapeutics's talent
Source: Dealroom Talent Intelligence.
Moderna Therapeutics mafia
Startups founded by Moderna Therapeutics alumni
Former Moderna Therapeutics employees who went on to start their own companies. Sorted by Dealroom signal score.
Jesse ChenUnited States
Sébastien BalasFrance
Axel BouchonUnited States
Flora BinderFrance
Nicholas ValianteUnited States
Kenneth ChienSweden
Andrew FraleyUnited States
Barry TichoUnited States
Noubar AfeyanUnited StatesGlobal footprint
Where Moderna Therapeutics has talent and traffic
team presence
across markets
Patent intelligence
$189M patent portfolio · 234 active families
Where Moderna Therapeutics concentrates vs peers
Each axis is a top-10 topic across Moderna Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Capital deployed
Moderna Therapeutics's 5 investments and acquisitions.
Every disclosed deal where Moderna Therapeutics appeared as a backer or acquirer, 2014–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
5 deals across Moderna Therapeutics's capital deployment.
Where the deals concentrate by sector, stage, and decade.
02 · Portfolio market map
Moderna Therapeutics's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Moderna Therapeutics
An AI-synthesized read of the highest-engagement posts about Moderna Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Moderna Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.